Aiden Haghikia - Publications

Ruhr-University Bochum/St. Josefs Hospital, Bochum, Nordrhein-Westfalen, Germany 

142 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Vogt S, Schlichte I, Schreiber S, Wigand B, Debska-Vielhaber G, Heitmann J, Meyer T, Dengler R, Petri S, Haghikia A, Vielhaber S. A Multi-Center Cohort Study on Characteristics of Pain, Its Impact and Pharmacotherapeutic Management in Patients with ALS. Journal of Clinical Medicine. 10. PMID 34640573 DOI: 10.3390/jcm10194552  1
2021 Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Döring Y, ... ... Haghikia A, et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. European Heart Journal. PMID 34597388 DOI: 10.1093/eurheartj/ehab644  1
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, ... ... Haghikia A, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders. 14: 17562864211039648. PMID 34422112 DOI: 10.1177/17562864211039648  1
2021 Wigand B, Schlichte I, Schreiber S, Heitmann J, Meyer T, Dengler R, Petri S, Haghikia A, Vielhaber S, Vogt S. Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis - a longitudinal study. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 34392762 DOI: 10.1080/21678421.2021.1962354  1
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, ... ... Haghikia A, et al. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt. PMID 34297142 DOI: 10.1007/s00115-021-01157-2  1
2021 Vockert N, Perosa V, Ziegler G, Schreiber F, Priester A, Spallazzi M, Garcia-Garcia B, Aruci M, Mattern H, Haghikia A, Düzel E, Schreiber S, Maass A. Hippocampal vascularization patterns exert local and distant effects on brain structure but not vascular pathology in old age. Brain Communications. 3: fcab127. PMID 34222874 DOI: 10.1093/braincomms/fcab127  1
2021 Haase S, Mäurer J, Duscha A, Lee DH, Balogh A, Gold R, Müller DN, Haghikia A, Linker RA. Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity Effects on Th17 Responses. Frontiers in Immunology. 12: 701626. PMID 34140958 DOI: 10.3389/fimmu.2021.701626  1
2021 Al-Nosairy KO, Horbrügger M, Schippling S, Wagner M, Haghikia A, Pawlitzki M, Hoffmann MB. Structure-Function Relationship of Retinal Ganglion Cells in Multiple Sclerosis. International Journal of Molecular Sciences. 22. PMID 33810342 DOI: 10.3390/ijms22073419  0.01
2021 Schreiber S, Haghikia A. From many, one: A call for meta-cohorts in neuromuscular ultrasound. European Journal of Neurology. PMID 33560538 DOI: 10.1111/ene.14767  1
2021 Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, Gold R, Lukas C, Haghikia A. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33172960 DOI: 10.1212/NXI.0000000000000906  1
2020 Haase S, Wilck N, Haghikia A, Gold R, Mueller DN, Linker RA. The role of the gut microbiota and microbial metabolites in neuroinflammation. European Journal of Immunology. PMID 33188704 DOI: 10.1002/eji.201847807  1
2020 Möhn N, Luo Y, Skripuletz T, Schwenkenbecher P, Ladwig A, Warnke C, Meuth SG, Wiendl H, Gross CC, Schröder C, Haghikia A, Stangel M. Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy. Fluids and Barriers of the Cns. 17: 65. PMID 33109245 DOI: 10.1186/s12987-020-00227-y  1
2020 Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J, Zelic M, Mahan A, Kothe M, Scholte AA, Fitzgerald M, ... ... Haghikia A, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death & Disease. 11: 904. PMID 33097690 DOI: 10.1038/s41419-020-03084-7  1
2020 Mehrjardi NZ, Molcanyi M, Hatay FF, Timmer M, Shahbazi E, Ackermann JP, Herms S, Heilmann-Heimbach S, Wunderlich TF, Prochnow N, Haghikia A, Lampert A, Hescheler J, Neugebauer EAM, Baharvand H, et al. Acquisition of chromosome 1q duplication in parental and genome-edited human-induced pluripotent stem cell-derived neural stem cells results in their higher proliferation rate in vitro and in vivo. Cell Proliferation. e12892. PMID 32918782 DOI: 10.1111/Cpr.12892  1
2020 Gold R, Montalban X, Haghikia A. Multiple sclerosis and nutrition: back to the future? Therapeutic Advances in Neurological Disorders. 13: 1756286420936165. PMID 32863887 DOI: 10.1177/1756286420936165  1
2020 Wurm H, Attfield K, Iversen AK, Gold R, Fugger L, Haghikia A. Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520943791. PMID 32762494 DOI: 10.1177/1352458520943791  1
2020 Waldera-Lupa DM, Poschmann G, Kirchgaessler N, Etemad-Parishanzadeh O, Baberg F, Brocksieper M, Seidel S, Kowalski T, Brunn A, Haghikia A, Gold R, Stefanski A, Deckert M, Schlegel U, Stühler K. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers. 12. PMID 32610669 DOI: 10.3390/Cancers12071732  1
2020 Ostendorf F, Metzdorf J, Gold R, Haghikia A, Tönges L. Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease. Molecules (Basel, Switzerland). 25. PMID 32481507 DOI: 10.3390/Molecules25112502  1
2020 Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, ... ... Haghikia A, et al. Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. PMID 32160527 DOI: 10.1016/J.Cell.2020.02.035  1
2020 Habib R, Ocklenburg S, Hoffjan S, Haghikia A, Epplen JT, Arning L. Association between shorter leukocyte telomeres and multiple sclerosis. Journal of Neuroimmunology. 341: 577187. PMID 32050150 DOI: 10.1016/J.Jneuroim.2020.577187  1
2020 Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease. Cells. 9. PMID 32041265 DOI: 10.3390/Cells9020376  1
2020 Linker RA, Haghikia A. Rolle des Darmes bei der Multiplen Sklerose Nervenheilkunde. 39: 42-46. DOI: 10.1055/A-1037-2166  1
2019 Meira M, Sievers C, Hoffmann F, Bodmer H, Derfuss T, Kuhle J, Haghikia A, Kappos L, Lindberg RL. PARP-1 deregulation in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319894604. PMID 31897308 DOI: 10.1177/2055217319894604  1
2019 Schäfer I, Kaisler J, Scheller A, Kirchhoff F, Haghikia A, Faissner A. Conditional Deletion of LRP1 Leads to Progressive Loss of Recombined NG2-Expressing Oligodendrocyte Precursor Cells in a Novel Mouse Model. Cells. 8. PMID 31801252 DOI: 10.3390/Cells8121550  1
2019 Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A, Kaisler J, Gisevius B, Gold R, Thum T, Haghikia A. Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e623. PMID 31575652 DOI: 10.1212/Nxi.0000000000000623  1
2019 Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, et al. [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Der Nervenarzt. PMID 31297574 DOI: 10.1007/S00115-019-0760-0  1
2019 Hirschberg S, Gisevius B, Duscha A, Haghikia A. Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases. International Journal of Molecular Sciences. 20. PMID 31242699 DOI: 10.3390/Ijms20123109  1
2019 Zorlu N, Hoffjan S, Haghikia A, Deyneko IV, Epplen JT. Evaluation of variation in genes of the arylhydrocarbon receptor pathway for an association with multiple sclerosis. Journal of Neuroimmunology. 334: 576979. PMID 31181469 DOI: 10.1016/J.Jneuroim.2019.576979  1
2019 Krogias C, Christou I, Tsivgoulis G, Koutroulou I, Schroeder C, Lantinioti C, Richter D, Karapanayiotides T, Haghikia A, Gold R, Voumvourakis K. Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30990241 DOI: 10.1111/Jon.12617  1
2019 Vohl K, Duscha A, Gisevius B, Kaisler J, Gold R, Haghikia A. Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis. Frontiers in Neurology. 10: 132. PMID 30853935 DOI: 10.3389/Fneur.2019.00132  1
2019 Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G. Serum neurofilaments increase at PML onset in natalizumab-treated MS patients. Annals of Neurology. PMID 30761586 DOI: 10.1002/Ana.25437  1
2019 Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease. Cells. 8. PMID 30708997 DOI: 10.3390/Cells8020105  1
2019 Gisevius B, Haghikia A, Hirschberg S. Impact of Diet and the Gut Microbiome on Neurodegeneration and Regeneration in Neurological Disorders Neuroforum. 25: 39-47. DOI: 10.1515/Nf-2018-0013  1
2018 Yoon MS, Pitarokoili K, Sturm D, Haghikia A, Gold R, Fisse AL. Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male. Therapeutic Advances in Neurological Disorders. 11: 1756286418809580. PMID 30542375 DOI: 10.1177/1756286418809580  1
2018 Zella S, Kneiphof J, Haghikia A, Gold R, Woitalla D, Thöne J. Successful therapy with rituximab in three patients with probable neurosarcoidosis. Therapeutic Advances in Neurological Disorders. 11: 1756286418805732. PMID 30386436 DOI: 10.1177/1756286418805732  1
2018 Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A. Peripheral CD19 B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders. Journal of Neurology. PMID 30377816 DOI: 10.1007/S00415-018-9092-4  1
2018 Haghikia A, Li XS, Liman TG, Bledau N, Schmidt D, Zimmermann F, Kränkel N, Widera C, Sonnenschein K, Haghikia A, Weissenborn K, Fraccarollo D, Heimesaat MM, Bauersachs J, Wang Z, et al. Gut Microbiota-Dependent Trimethylamine -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 29976769 DOI: 10.1161/Atvbaha.118.311023  1
2018 Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A. Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis. Clinical Neurology and Neurosurgery. 172: 24-26. PMID 29960102 DOI: 10.1016/J.Clineuro.2018.06.005  1
2018 Motte J, Kneiphof J, Straßburger-Krogias K, Klasing A, Adams O, Haghikia A, Gold R. Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML. Journal of Neurology. PMID 29948248 DOI: 10.1007/S00415-018-8931-7  1
2018 Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, Gold R, Linker RA. The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 668-676. PMID 29928650 DOI: 10.1002/Acn3.553  1
2018 Haase S, Haghikia A, Wilck N, Müller DN, Linker RA. Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology. PMID 29637999 DOI: 10.1111/Imm.12933  1
2018 Haghikia A, Linker RA. Ernährung, Mikrobiom und Multiple Sklerose Nervenarzt. 89: 463-471. PMID 29516151 DOI: 10.1007/S00115-018-0497-1  1
2018 Matveeva O, Bogie JFJ, Hendriks JJA, Linker RA, Haghikia A, Kleinewietfeld M. Western lifestyle and immunopathology of multiple sclerosis. Annals of the New York Academy of Sciences. 1417: 71-86. PMID 29377214 DOI: 10.1111/Nyas.13583  1
2018 Haase S, Haghikia A, Gold R, Linker RA. Dietary fatty acids and susceptibility to multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 12-16. PMID 29307296 DOI: 10.1177/1352458517737372  1
2018 Haghikia A, Linker R. Diät, Mikrobiom und Multiple Sklerose Aktuelle Neurologie. 45: 24-28. DOI: 10.1055/S-0043-111789  1
2017 Hammer A, Waschbisch A, Knippertz I, Zinser E, Berg J, Jörg S, Kuhbandner K, David C, Pi J, Bayas A, Lee DH, Haghikia A, Gold R, Steinkasserer A, Linker RA. Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells. Frontiers in Immunology. 8: 1922. PMID 29312359 DOI: 10.3389/Fimmu.2017.01922  1
2017 Hammer A, Schliep A, Jörg S, Haghikia A, Gold R, Kleinewietfeld M, Müller DN, Linker RA. Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation. Journal of Neuroinflammation. 14: 184. PMID 28899400 DOI: 10.1186/S12974-017-0954-Y  1
2017 Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S, Linker RA, Gold R, Haghikia A. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. The American Journal of Pathology. 187: 1613-1622. PMID 28634006 DOI: 10.1016/J.Ajpath.2017.03.006  1
2017 Schneider R, Bellenberg B, Hoepner R, Kolb EM, Ellrichmann G, Haghikia A, Gold R, Lukas C. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). Plos One. 12: e0176415. PMID 28445498 DOI: 10.1371/Journal.Pone.0176415  1
2017 Haghikia A, Yanchev GR, Kayacelebi AA, Hanff E, Bledau N, Widera C, Sonnenschein K, Haghikia A, Weissenborn K, Bauersachs J, Bavendiek U, Tsikas D. The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients. Amino Acids. 49: 1111-1121. PMID 28285332 DOI: 10.1007/S00726-017-2409-2  1
2017 Haghikia A, Dendrou CA, Schneider R, Grüter T, Postert T, Matzke M, Stephanik H, Fugger L, Gold R. Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. The Lancet. Neurology. 16: 104-106. PMID 28102146 DOI: 10.1016/S1474-4422(16)30382-9  1
2016 Haghikia A, Gold R. Active immunotherapy may delay disability in progressive MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27683917 DOI: 10.1136/Jnnp-2016-314377  1
2016 Berg J, Mahmoudjanlou Y, Duscha A, Massa MG, Thöne J, Esser C, Gold R, Haghikia A. The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor. Journal of Neuroimmunology. 298: 9-15. PMID 27609269 DOI: 10.1016/J.Jneuroim.2016.06.003  1
2016 Jörg S, Grohme DA, Erzler M, Binsfeld M, Haghikia A, Müller DN, Linker RA, Kleinewietfeld M. Environmental factors in autoimmune diseases and their role in multiple sclerosis. Cellular and Molecular Life Sciences : Cmls. PMID 27491297 DOI: 10.1007/S00018-016-2311-1  1
2016 Linker RA, Haghikia A. Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy. Therapeutic Advances in Chronic Disease. 7: 198-207. PMID 27433310 DOI: 10.1177/2040622316653307  1
2016 Décard BF, Thöne J, Haghikia A, Börnke C, Anders A, Lukas C, Gold R. Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27430683 DOI: 10.1177/1352458516650522  1
2016 Faissner S, Nikolayczik J, Chan A, Gold R, Yoon MS, Haghikia A. Immunoadsorption in patients with neuromyelitis optica spectrum disorder. Therapeutic Advances in Neurological Disorders. 9: 281-6. PMID 27366234 DOI: 10.1177/1756285616646332  1
2016 Massa MG, Gisevius B, Hirschberg S, Hinz L, Schmidt M, Gold R, Prochnow N, Haghikia A. Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells. Plos One. 11: e0155274. PMID 27158987 DOI: 10.1371/Journal.Pone.0155274  1
2016 Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 44: 951-953. PMID 27096322 DOI: 10.1016/j.immuni.2016.04.006  1
2016 Meira M, Sievers C, Hoffmann F, Haghikia A, Rasenack M, Décard BF, Kuhle J, Derfuss T, Kappos L, Lindberg RL. Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development. Neurology® Neuroimmunology & Neuroinflammation. 3: e223. PMID 27088119 DOI: 10.1212/Nxi.0000000000000223  1
2016 Kerasnoudis A, Pitarokoili K, Haghikia A, Gold R, Yoon MS. Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies. Muscle & Nerve. PMID 27061901 DOI: 10.1002/Mus.25138  1
2016 Faissner S, Nikolayczik J, Chan A, Hellwig K, Gold R, Yoon MS, Haghikia A. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses. Journal of Neurology. PMID 27039388 DOI: 10.1007/S00415-016-8105-4  1
2016 Jörg S, Kissel J, Manzel A, Kleinewietfeld M, Haghikia A, Gold R, Müller DN, Linker RA. High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells. Experimental Neurology. 279: 212-222. PMID 26976739 DOI: 10.1016/J.Expneurol.2016.03.010  1
2016 Haghikia A, Gold R. Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome. Jama Neurology. PMID 26954938 DOI: 10.1001/Jamaneurol.2015.5050  1
2016 Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, et al. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt. PMID 26927677 DOI: 10.1007/S00115-016-0077-1  1
2016 Thiel S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26920382 DOI: 10.1177/1352458516634872  1
2016 Akkad DA, Lee DH, Bruch K, Haghikia A, Epplen JT, Hoffjan S, Linker RA. Multiple sclerosis in families: risk factors beyond known genetic polymorphisms. Neurogenetics. PMID 26865406 DOI: 10.1007/S10048-016-0474-4  1
2016 Herbstritt S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K. Glatiramer acetate during early pregnancy: A prospective cohort study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754804 DOI: 10.1177/1352458515623366  1
2015 Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 43: 817-29. PMID 26488817 DOI: 10.1016/J.Immuni.2015.09.007  1
2015 Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B, Menck S, Gold R, Langer-Gould A. Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. Jama Neurology. 72: 1132-8. PMID 26322399 DOI: 10.1001/Jamaneurol.2015.1806  1
2015 Kolber P, Luessi F, Meuth SG, Klotz L, Korn T, Trebst C, Tackenberg B, Kieseier B, Kümpfel T, Fleischer V, Tumani H, Wildemann B, Lang M, Flachenecker P, Meier U, ... ... Haghikia A, et al. [Current aspects of therapy conversion for multiple sclerosis]. Der Nervenarzt. 86: 1236-47. PMID 26269289 DOI: 10.1007/S00115-015-4368-8  1
2015 Haghikia A, Kayacelebi AA, Beckmann B, Hanff E, Gold R, Haghikia A, Tsikas D. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica. Amino Acids. 47: 1837-45. PMID 26055922 DOI: 10.1007/S00726-015-2015-0  1
2015 Akkad DA, Olischewsky A, Reiner F, Hellwig K, Esser S, Epplen JT, Curk T, Gold R, Haghikia A. Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity. Plos One. 10: e0127632. PMID 26011527 DOI: 10.1371/Journal.Pone.0127632  1
2015 Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry. Multiple Sclerosis and Related Disorders. 4: 264-72. PMID 26008944 DOI: 10.1016/J.Msard.2015.04.003  1
2015 Haghikia A, Gold R. [Is the use of placebo as control group in MS drug trials still appropriate?]. Der Nervenarzt. 86: 481-2. PMID 25787726 DOI: 10.1007/S00115-015-4283-Z  1
2015 Akkad DA, Bellenberg B, Esser S, Weiler F, Epplen JT, Gold R, Lukas C, Haghikia A. Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability. Neurogenetics. 16: 161-8. PMID 25620546 DOI: 10.1007/S10048-015-0438-0  1
2014 Haghikia A, Faissner S, Pappas D, Pula B, Akkad DA, Arning L, Ruhrmann S, Duscha A, Gold R, Baranzini SE, Malhotra S, Montalban X, Comabella M, Chan A. Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25480861 DOI: 10.1177/1352458514561909  1
2014 Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. Jama Neurology. 71: 891-5. PMID 24821217 DOI: 10.1001/Jamaneurol.2014.209  1
2014 Haghikia A, Linker R, Gold R. [Fumaric acid as therapeutic agent for multiple sclerosis]. Der Nervenarzt. 85: 720-6. PMID 24668400 DOI: 10.1007/S00115-014-4005-Y  1
2014 Haghikia A, Gold R. Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS. Nature Reviews. Neurology. 10: 183-4. PMID 24638132 DOI: 10.1038/Nrneurol.2014.42  1
2014 Berg J, Bytko X, Waldhoff C, Gold R, Haghikia A. Effect of MS-related miRNA on astrocytic proliferation Journal of Neuroimmunology. 275: 111. DOI: 10.1016/J.Jneuroim.2014.08.298  1
2014 Duscha A, Berg J, Thöne J, Demir S, Gold R, Haghikia A. Beneficial effects of short chain fatty acids on the course of experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 275: 59. DOI: 10.1016/J.Jneuroim.2014.08.154  1
2013 Prochnow N, Gold R, Haghikia A. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 264: 48-53. PMID 24090654 DOI: 10.1016/J.Jneuroim.2013.09.012  1
2013 Haghikia A, Gold R. [Multiple sclerosis: oral drugs]. Mmw Fortschritte Der Medizin. 155: 54-6. PMID 24006598 DOI: 10.1007/S15006-013-2042-2  1
2013 Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends in Molecular Medicine. 19: 309-19. PMID 23582699 DOI: 10.1016/J.Molmed.2013.03.004  1
2013 Décard BF, Haghikia A, Tönnes C, Thöne J, Lukas C, Chan A, Gold R. Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 249-51. PMID 22596228 DOI: 10.1177/1352458512448268  1
2013 Burek M, Haghikia A, Gold R, Roewer N, Chan A, Frster CY. Differential Cytokine Release from Brain Microvascular Endothelial Cells Treated with Dexamethasone and Multiple Sclerosis Patient Sera Journal of Steroids & Hormonal Science. 5: 1-8. DOI: 10.4172/2157-7536.1000128  1
2012 Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T, Gold R. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology. 79: 2166-70. PMID 23077021 DOI: 10.1212/Wnl.0B013E3182759621  1
2012 Hellwig K, Haghikia A, Rockhoff M, Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Therapeutic Advances in Neurological Disorders. 5: 247-53. PMID 22973421 DOI: 10.1177/1756285612453192  1
2012 Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, Poschmann G, Kaur G, Lambert L, Leach OA, Prömel S, Punwani D, Felce JH, Davis SJ, Gold R, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 488: 508-11. PMID 22801493 DOI: 10.1038/Nature11307  1
2012 Thöne J, Ellrichmann G, Faustmann PM, Gold R, Haghikia A. Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis. International Immunopharmacology. 14: 9-12. PMID 22691576 DOI: 10.1016/J.Intimp.2012.05.021  1
2012 Trampe AK, Hemmelmann C, Stroet A, Haghikia A, Hellwig K, Wiendl H, Goelz S, Ziegler A, Gold R, Chan A. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology. 78: 1736-42. PMID 22592369 DOI: 10.1212/Wnl.0B013E3182583022  1
2012 Haghikia A, Décard BF, Hellwig K, Kraus P, Gold R. Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington's disease. Journal of Neurology. 259: 1973-5. PMID 22460588 DOI: 10.1007/S00415-012-6484-8  1
2012 Gambichler T, Scola N, Rotterdam S, Höxtermann S, Haghikia A, Faissner S, Kreuter A, Bechara FG, Altmeyer P, Chan A. Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters. Acta Dermato-Venereologica. 92: 364-6. PMID 22294455 DOI: 10.2340/00015555-1266  1
2012 Minwegen D, Poschmann G, Stuehler K, Faissner S, Haghikia A, Meyer H, Gold R, Chan A. Astrocytes Secrete Bridging Molecules That May Be Responsible for Increased Microglial Uptake of Apoptotic Inflammatory Cells (P07.090) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.090  1
2012 Hellwig K, Haghikia A, Gold R. Natalizumab and Pregnancy - Results from the German MS and Pregnancy Registry (P06.187) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.187  1
2011 Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 958-63. PMID 21613333 DOI: 10.1177/1352458511401944  1
2011 Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Molecular Neurodegeneration. 6: 32. PMID 21595933 DOI: 10.1186/1750-1326-6-32  1
2011 Haghikia A, Perrech M, Pula B, Ruhrmann S, Potthoff A, Brockmeyer NH, Goelz S, Wiendl H, LindÃ¥ H, Ziemssen T, Baranzini SE, Käll TB, Bengel D, Olsson T, Gold R, et al. Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders. Plos One. 6: e18506. PMID 21533133 DOI: 10.1371/Journal.Pone.0018506  1
2011 Sørensen PS, Jensen PE, Haghikia A, Lundkvist M, Vedeler C, Sellebjerg F, Koch-Henriksen N, Fogdell-Hahn A, Myhr KM, Hillert J, Gold R. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1074-8. PMID 21511692 DOI: 10.1177/1352458511404271  1
2011 Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O, Zéphir H, Gold R. Managing MS in a changing treatment landscape. Journal of Neurology. 258: 728-39. PMID 21437661 DOI: 10.1007/S00415-011-6009-X  1
2011 Hinkerohe D, Wolfkühler D, Haghikia A, Meier C, Faustmann PM, Schlegel U. Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro. Journal of Neuro-Oncology. 103: 479-89. PMID 21107646 DOI: 10.1007/S11060-010-0456-6  1
2011 Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, Muckenthaler MU, Eder M, Stapel B, Thum T, Haghikia A, Petrasch-Parwez E, Drexler H, Hilfiker-Kleiner D, Scherr M. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. European Heart Journal. 32: 1287-97. PMID 20965886 DOI: 10.1093/Eurheartj/Ehq369  1
2011 Stienen MN, Haghikia A, Dambach H, Thöne J, Wiemann M, Gold R, Chan A, Dermietzel R, Faustmann PM, Hinkerohe D, Prochnow N. Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation. British Journal of Pharmacology. 162: 491-507. PMID 20955362 DOI: 10.1111/J.1476-5381.2010.01038.X  1
2010 Haghikia A, Gold R. The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation. The American Journal of Pathology. 176: 2599-601. PMID 20395429 DOI: 10.2353/Ajpath.2010.100200  1
2010 Hinkerohe D, Smikalla D, Schoebel A, Haghikia A, Zoidl G, Haase CG, Schlegel U, Faustmann PM. Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model. Brain Research. 1329: 45-54. PMID 20230803 DOI: 10.1016/J.Brainres.2010.03.012  1
2010 Lafenêtre P, Leske O, Ma-Högemeie Z, Haghikia A, Bichler Z, Wahle P, Heumann R. Exercise can rescue recognition memory impairment in a model with reduced adult hippocampal neurogenesis. Frontiers in Behavioral Neuroscience. 3: 34. PMID 20204139 DOI: 10.3389/Neuro.08.034.2009  0.01
2010 Blecharz KG, Haghikia A, Stasiolek M, Kruse N, Drenckhahn D, Gold R, Roewer N, Chan A, Förster CY. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 293-302. PMID 20203147 DOI: 10.1177/1352458509358189  1
2010 Arning L, Haghikia A, Taherzadeh-Fard E, Saft C, Andrich J, Pula B, Höxtermann S, Wieczorek S, Akkad DA, Perrech M, Gold R, Epplen JT, Chan A. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. Journal of Molecular Medicine (Berlin, Germany). 88: 431-6. PMID 20108082 DOI: 10.1007/S00109-010-0589-2  1
2010 Hellwig K, Haghikia A, Gold R. Parenthood and immunomodulation in patients with multiple sclerosis. Journal of Neurology. 257: 580-3. PMID 19936821 DOI: 10.1007/S00415-009-5376-Z  1
2010 Haghikia A, Gold R. Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system. Journal of Neuroimmunology. 218: 1-2. PMID 19879005 DOI: 10.1016/J.Jneuroim.2009.09.018  1
2009 Hellwig K, Haghikia A, Agne H, Beste C, Gold R. Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Archives of Neurology. 66: 1580-1; author reply. PMID 20008670 DOI: 10.1001/Archneurol.2009.281  1
2009 Meves SH, Salmen S, Monnings P, Haghikia A, Gold R, Krogias C. The agony of choice: diagnosis of cervical artery dissection by means of duplexsonography or magnetic resonance imaging? Cerebrovascular Diseases (Basel, Switzerland). 28: 626-8. PMID 19887794 DOI: 10.1159/000253148  1
2009 Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. The New England Journal of Medicine. 361: 1075-80. PMID 19741228 DOI: 10.1056/Nejmoa0810257  1
2009 Haghikia A, Gold R. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis? Experimental Neurology. 217: 240-1. PMID 19361499 DOI: 10.1016/J.Expneurol.2009.03.041  1
2009 Lee A, Rudkin A, Agzarian M, Patel S, Lake S, Chen C, Sanossian N, Starkman S, Liebeskind DS, Ali LK, Restrepo L, Hamilton S, Conwit R, Saver JL, Vaartjes I, ... ... Haghikia A, et al. Contents Vol. 28, 2009 Cerebrovascular Diseases. 28. DOI: 10.1159/000262294  1
2009 Lee A, Rudkin A, Agzarian M, Patel S, Lake S, Chen C, Sanossian N, Starkman S, Liebeskind DS, Ali LK, Restrepo L, Hamilton S, Conwit R, Saver JL, Vaartjes I, ... ... Haghikia A, et al. Subject Index Vol. 28, 2009 Cerebrovascular Diseases. 28: 634-636. DOI: 10.1159/000262289  1
2009 Martin L, Leist A, Hinkerohe D, Hellwig K, Chan A, Gold R, Faustmann P, Haghikia A. Kopplungseffizienz und Membranruhepotential von Astrozyten unter CXCL-8 Aktuelle Neurologie. 36: 689. DOI: 10.1055/S-0029-1238782  1
2009 Leist A, Prochnow N, Martin L, Hinkerohe D, Chan A, Gold R, Faustmann P, Haghikia A. Wirkung des Chemokins CXCL-8 auf elektrophysiologische und morphologische Eigenschaften der Mikroglia Aktuelle Neurologie. 36: 687. DOI: 10.1055/S-0029-1238780  1
2009 Dambach H, Hinkerohe D, Haghikia A, Berthold C, Zülow E, Schöbel A, Schlegel U, Faustmann P. Dexamethason reduziert die interzelluläre Kopplung in F98, C6 und U87 Gliom-Zelllinien und erhöht die TGF-β1 Produktion Aktuelle Neurologie. 36: 647. DOI: 10.1055/S-0029-1238740  1
2009 Berthold C, Hinkerohe D, Haghikia A, Schöbel A, Zülow E, Dambach H, Schlegel U, Faustmann P. TGF-β1 reduziert gap-junctionale Kopplung in C6, F98 und U87 Gliom-Zelllinien Aktuelle Neurologie. 36: 646. DOI: 10.1055/S-0029-1238739  1
2009 Schöbel A, Hinkerohe D, Smikalla D, Haghikia A, Berthold C, Zülow E, Dambach H, Schlegel U, Faustmann P. Einfluss von Dexamethason auf Lipolysaccharid induzierte Veränderungen in einem glialen Ko-Kulturmodell in vitro Aktuelle Neurologie. 36: 526. DOI: 10.1055/S-0029-1238620  1
2009 Hellwig K, Haghikia A, Gold R. Vaterschaft und Immunodulation bei Patienten mit Multipler Sklerose Aktuelle Neurologie. 36: 488. DOI: 10.1055/S-0029-1238582  1
2009 Zülow E, Hinkerohe D, Prochnow N, Schöbel A, Berthold C, Dambach H, Haghikia A, Schlegel U, Faustmann P. Aktivierte Mikroglia depolarisiert Astrozyten und Neuronen – Untersuchungen in einem Triple-Ko-Kultur-Modell Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238354  1
2008 Hellwig K, Schimrigk S, Fischer M, Haghikia A, Müller T, Chan A, Gold R. Allergic and nonallergic delayed infusion reactions during natalizumab therapy. Archives of Neurology. 65: 656-8. PMID 18474743 DOI: 10.1001/Archneur.65.5.656  1
2008 Haghikia A, Fischer M, Hellwig K, Linker R, Chan A, Hohlfeld R, Gold R. Open use of natalizumab. Neutralising antibodies and clinical data Nervenarzt. 79: 716-719. PMID 18437340 DOI: 10.1007/S00115-008-2464-8  1
2008 Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S, Gold R. Increased MS relapse rate during assisted reproduction technique. Journal of Neurology. 255: 592-3. PMID 18408881 DOI: 10.1007/S00415-008-0607-2  1
2008 Haghikia A, Ladage K, Hinkerohe D, Vollmar P, Heupel K, Dermietzel R, Faustmann PM. Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. Journal of Neuroscience Research. 86: 1781-8. PMID 18335543 DOI: 10.1002/Jnr.21639  1
2008 Hellwig K, Brune N, Haghikia A, Müller T, Schimrigk S, Schwödiauer V, Gold R. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients Acta Neurologica Scandinavica. 118: 24-28. PMID 18205883 DOI: 10.1111/J.1600-0404.2007.00978.X  1
2008 Haghikia A, Ladage K, Lafênetre P, Haghikia A, Hinkerohe D, Smikalla D, Haase CG, Dermietzel R, Faustmann PM. Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. Journal of Neuro-Oncology. 86: 143-52. PMID 17690839 DOI: 10.1007/S11060-007-9462-8  1
2008 Vollmar P, Haghikia A, Dermietzel R, Faustmann PM. Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. The International Journal of Neuropsychopharmacology. 11: 111-7. PMID 17445357 DOI: 10.1017/S1461145707007729  1
2008 Haghikia A, Perrech M, Harati K, Gold R, Saft C, Chan A. ATP-Produktion in Immunzellen von M. Huntington Patienten Aktuelle Neurologie. 35: 550. DOI: 10.1055/S-0028-1086804  1
2008 Hinkerohe D, Prochnow N, Haghikia A, Schlegel U, Dermietzel R, Faustmann PM. Mikrogliale Aktivierung bewirkt neuronale Depolarisation – ein Ko-Kultur-Modell für Neuroinflammation Aktuelle Neurologie. 35: 469. DOI: 10.1055/S-0028-1086723  1
2008 Haghikia A, Fischer M, Hellwig K, Linker R, Chan A, Hohlfeld R, Gold R. Natalizumab im klinischen Alltag Nervenarzt. 79: 716-719. DOI: 10.1007/S00115-008-2558-3  1
2007 Wolfkühler D, Hinkerohe D, Haghikia A, Schlegel U, Dermietzel R, Meier C, Faustmann PM. Effekte des immunsuppressiven Zytokins TGF-b1 auf ein Gliom-Modell in vitro Aktuelle Neurologie. 34: 765. DOI: 10.1055/S-2007-988034  1
2007 Hinkerohe D, Wolfkühler D, Haghikia A, Schlegel U, Dermietzel R, Meier C, Faustmann PM. Dexamethason reduziert Gap-Junctionale Kopplung in F98 und U87 Gliom-Zelllinien Aktuelle Neurologie. 34: 764. DOI: 10.1055/S-2007-988033  1
2007 Faustmann PM, Haghikia A, Smikalla D, Hinkerohe D, Chan A, Dermietzel R. Entkopplung des astrozytären Synzytiums durch Liquores von Multiple Sklerose Patienten Aktuelle Neurologie. 34: 736. DOI: 10.1055/S-2007-988006  1
2007 Haghikia A, Hellwig K, Fischer M, Brune N, Schimrigk S, Chan A, Gold R. Natalizumab (Tysabri®) neun Monate nach der Zulassung im klinischen Alltag: neutralisierende Antikörper und klinische Daten Aktuelle Neurologie. 34: 735. DOI: 10.1055/S-2007-988005  1
2007 Hellwig K, Haghikia A, Schimrigk S, Gold R. Kinderwunsch und Multiple Sklerose Einstellungs- und Verschreibungsverhalten deutschsprachiger Neurologen Aktuelle Neurologie. 34: 495. DOI: 10.1055/S-2007-987766  1
2005 Hinkerohe D, Smikalla D, Haghikia A, Heupel K, Haase CG, Dermietzel R, Faustmann PM. Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia. 52: 85-97. PMID 15920725 DOI: 10.1002/Glia.20223  1
2005 Hinkerohe D, Haghikia A, Ladage K, Smikalla D, Haase CG, Dermietzel R, Faustmann PM. Transforming Growth Factor-b1 (TGF-b1) normalisiert die entzündlich bedingte Entkopplung des astroglialen Synzytiums Aktuelle Neurologie. 32: 365. DOI: 10.1055/S-2005-919399  1
2004 Ladage K, Haghikia A, Hinkerohe D, Smikalla D, Dermietzel R, Faustmann PM. Levetiracetam normalisiert die Connexin 43 Expression und die interzelluläre Kommunikation in primären Astrozytenkulturen Aktuelle Neurologie. 31: 253. DOI: 10.1055/S-2004-833116  1
Show low-probability matches.